CIR

CIRCADIAN TECHNOLOGIES LIMITED - Announcements

0.00%

31.0¢

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CIR	FDA GRANTS HUMANITARIAN USE DEVICE DESIGNATION TO VEGF-D KIT	PRICE SENSITIVE	02/07/13	113.7KB	Share
CIR	US patent granted covering use of VEGFR-3	PRICE SENSITIVE	17/06/13	81.39KB	Share
CIR	VGX-100 Phase 1 oncology trial presented at ASCO 2013	PRICE SENSITIVE	04/06/13	1.51MB	Share
CIR	Change of Director's Interest Notice		27/05/13	394.45KB	Share
CIR	Open Briefing		24/05/13	241.55KB	Share
CIR	Change of Director's Interest Notice		23/05/13	394.39KB	Share
CIR	Change of Director's Interest Notice		20/05/13	379.49KB	Share
CIR	Progress of VGX-100 Phase 1 trial to be presented at ASCO		17/05/13	102.19KB	Share
CIR	VEGF-C shown to have major role in (AMD)	PRICE SENSITIVE	09/05/13	780.59KB	Share
CIR	VEGF-C shown to have major role in (AMD)	PRICE SENSITIVE	09/05/13	168.95KB	Share
CIR	Circadian grants world-wide licence to Santa Cruz	PRICE SENSITIVE	08/03/13	77.42KB	Share
CIR	CIRCADIAN COMMENCES WORDWIDE MARKETING AND SALES OF REAGENTS	PRICE SENSITIVE	27/02/13	164.79KB	Share
CIR	Open Briefing CEO on Half Year Results and Outlook		25/02/13	315.92KB	Share
CIR	Company Secretary Appointment/Resignation		22/02/13	22.25KB	Share
CIR	Company Secretary Appointment/Resignation		20/02/13	21.9KB	Share
CIR	Half Year Report & Accounts	PRICE SENSITIVE	18/02/13	409.53KB	Share
CIR	R&D Tax Incentive - Circadian Receives $1.3m	PRICE SENSITIVE	07/02/13	26.94KB	Share
CIR	VGX-100 Phase 1 Clinical Trial Program Update	PRICE SENSITIVE	04/02/13	1.08MB	Share
CIR	Company Presentation at JP Morgan Biotech Showcase		10/01/13	3.21MB	Share
CIR	Change of Director's Interest Notice		17/12/12	71.13KB	Share
CIR	Open Briefing - CEO on Business Separation		11/12/12	210.4KB	Share
CIR	Change of Director's Interest Notice		21/11/12	71.26KB	Share
CIR	Appendix 3B		21/11/12	122.67KB	Share
CIR	Results of Meeting		20/11/12	40.12KB	Share
CIR	CEO AGM Presentation to shareholders		20/11/12	1.29MB	Share
CIR	Chairman's Address to Shareholders		20/11/12	253.66KB	Share
CIR	Licence Grant To Bio-Rad	PRICE SENSITIVE	15/11/12	32.36KB	Share
CIR	VGX-100 Poster Presentation at EORTC	PRICE SENSITIVE	08/11/12	315.62KB	Share
CIR	VGX-100 Top 10 oncology candidate Windhover Conference		07/11/12	32.34KB	Share
CIR	AusBiotech Presentation Company Update		02/11/12	951.89KB	Share
CIR	Annual Report / Notice of AGM & Proxy Form		22/10/12	1.39MB	Share
CIR	Director Appointment/Resignation		02/10/12	25.96KB	Share
CIR	Open Briefing		24/09/12	304.54KB	Share
CIR	Appendix 3B		24/08/12	122.36KB	Share
CIR	Notice under section 708A(5)(e) of the Corporations Act 2001		24/08/12	23.47KB	Share
CIR	Preliminary Final Report	PRICE SENSITIVE	23/08/12	1.31MB	Share
PER +CIR	Change in substantial holding from CIR		17/07/12	42.05KB	Share
CIR	Appendix 3Y		12/07/12	37.55KB	Share
CIR	Appendix 3Y		10/07/12	37.49KB	Share
CIR	Analyst Report on Website		09/07/12	28.33KB	Share
CIR	Commercial launch of CUP Test	PRICE SENSITIVE	27/06/12	46.09KB	Share
CIR	Appendix 3B		22/06/12	121.86KB	Share
CIR	708A Notice		22/06/12	23.46KB	Share
CIR	Placement	PRICE SENSITIVE	12/06/12	37.49KB	Share
CIR	Reinstatement to Official Quotation	PRICE SENSITIVE	12/06/12	30.35KB	Share
CIR	Suspension From Official Quotation	PRICE SENSITIVE	06/06/12	77.8KB	Share
CIR	Company's Request for Suspension		06/06/12	124.26KB	Share
CIR	Request for Trading Halt		05/06/12	23.46KB	Share
CIR	Trading Halt	PRICE SENSITIVE	05/06/12	30.43KB	Share
CIR	Updated Corporate Presentation		01/06/12	1.42MB	Share
CIR	Appendix 3B		16/05/12	112.38KB	Share
CIR	Ceasing to be a substantial holder		26/04/12	42KB	Share
CIR	Change of Director's Interest Notice		02/04/12	29.16KB	Share
PER +CIR	Change in substantial holding from CIR - Updated		30/03/12	43.29KB	Share
CIR	Change in substantial holding - ANP		29/03/12	43.58KB	Share
CIR	Analyst Report on Website		15/03/12	28.42KB	Share
CIR	Healthscope publishes data on CUP Test	PRICE SENSITIVE	09/03/12	273.54KB	Share
CIR	Open Briefing - CEO on H1 Results and Outlook	PRICE SENSITIVE	20/02/12	326.06KB	Share
CIR	Half Yearly Report and Accounts	PRICE SENSITIVE	16/02/12	432.74KB	Share
CIR	VGX-100 potential for improving corneal graft survival	PRICE SENSITIVE	30/01/12	40.29KB	Share
CIR	CEO Presentation at Biotech Showcase San Francisco		12/01/12	1.14MB	Share
CIR	Circadian commences first Phase 1 clinical trial of VGX-100	PRICE SENSITIVE	09/01/12	32.42KB	Share
CIR	Change of Director's Interest Notice		21/12/11	34.37KB	Share
CIR	Finance News Network Interview with CEO		19/12/11	28.8KB	Share
CIR	Change of Director's Interest Notice		13/12/11	39.41KB	Share
CIR	Final Director's Interest Notice		25/11/11	17.51KB	Share
CIR	Results of Meeting		24/11/11	38.37KB	Share
CIR	CEO Presentation to AGM		24/11/11	702.45KB	Share
CIR	AGM Chairman's Address to Shareholders		24/11/11	45.11KB	Share
CIR	Open Briefing - CEO on IND Status for VGX-100	PRICE SENSITIVE	15/11/11	332.69KB	Share
CIR	FDA approves IND for VGX-100	PRICE SENSITIVE	31/10/11	183.66KB	Share
CIR	Change of Director's Interest Notice		25/10/11	33.94KB	Share
CIR	Notice of Annual General Meeting/Proxy Form/Annual Report		24/10/11	2.62MB	Share
CIR	Change of Director's Interest Notice		20/10/11	33.99KB	Share
CIR	Final Director's Interest Notice		18/10/11	17.59KB	Share
CIR	Analyst Investment Reports on Circadian Website		11/10/11	29.31KB	Share
CIR	Circadian Corporate Presentation to Biopartnering Europe		11/10/11	1.27MB	Share
CIR	Clinical validation study of CUP Test commences	PRICE SENSITIVE	10/10/11	50.18KB	Share
CIR	Retirements from Circadian Board of Directors		03/10/11	28.08KB	Share
CIR	Circadian files IND with FDA for VGX-100	PRICE SENSITIVE	30/09/11	45.83KB	Share
CIR	Open Briefing - CEO on FY12 Outlook and VGX-100 Progress	PRICE SENSITIVE	15/09/11	366.46KB	Share
CIR	VGX-100 potential new therapy for Dry Eye Disease	PRICE SENSITIVE	13/09/11	41.45KB	Share
CIR	Key appointment in clinical trials management		12/09/11	30.01KB	Share
CIR	Change of Director's Interest Notice		09/09/11	25.29KB	Share
CIR	Change of Director's Interest Notice		07/09/11	25.33KB	Share
CIR	Change of Director's Interest Notice		07/09/11	24.92KB	Share
CIR	Updated Corporate Presentation		07/09/11	2.91MB	Share
CIR	Change of Director's Interest Notice		06/09/11	25.31KB	Share
CIR +OIL	Change in substantial holding from CIR		31/08/11	31.09KB	Share
CIR	Change of Director's Interest Notice		31/08/11	25.33KB	Share
CIR	Change of Director's Interest Notice		30/08/11	28.46KB	Share
CIR	Preliminary Final Report	PRICE SENSITIVE	23/08/11	1.19MB	Share
CIR	Change of Director's Interest Notice		25/07/11	29.13KB	Share
CIR	Change of Director's Interest Notice		18/07/11	28.46KB	Share
CIR	Open Briefing - CEO on VGX-100 Clinical Development Plans	PRICE SENSITIVE	14/07/11	313.09KB	Share
CIR	Market Update Presentation		16/06/11	2.7MB	Share
CIR	Circadian launches level 1 ADR Program and OTCQX in US	PRICE SENSITIVE	14/06/11	58.59KB	Share
PER +CIR	Change in substantial holding from CIR		10/06/11	28.77KB	Share
CIR	VEGF-C and VEGF-D Identified as Biomarkers	PRICE SENSITIVE	07/06/11	542.49KB	Share
CIR	Analyst Investment Reports on Circadian Website		30/05/11	26.05KB	Share

CIRFDA GRANTS HUMANITARIAN USE DEVICE DESIGNATION TO VEGF-D KIT
02/07/13	PRICE SENSITIVE	113.7KB	Share
CIRUS patent granted covering use of VEGFR-3
17/06/13	PRICE SENSITIVE	81.39KB	Share
CIRVGX-100 Phase 1 oncology trial presented at ASCO 2013
04/06/13	PRICE SENSITIVE	1.51MB	Share
CIRChange of Director's Interest Notice
27/05/13		394.45KB	Share
CIROpen Briefing
24/05/13		241.55KB	Share
CIRChange of Director's Interest Notice
23/05/13		394.39KB	Share
CIRChange of Director's Interest Notice
20/05/13		379.49KB	Share
CIRProgress of VGX-100 Phase 1 trial to be presented at ASCO
17/05/13		102.19KB	Share
CIRVEGF-C shown to have major role in (AMD)
09/05/13	PRICE SENSITIVE	780.59KB	Share
CIRVEGF-C shown to have major role in (AMD)
09/05/13	PRICE SENSITIVE	168.95KB	Share
CIRCircadian grants world-wide licence to Santa Cruz
08/03/13	PRICE SENSITIVE	77.42KB	Share
CIRCIRCADIAN COMMENCES WORDWIDE MARKETING AND SALES OF REAGENTS
27/02/13	PRICE SENSITIVE	164.79KB	Share
CIROpen Briefing CEO on Half Year Results and Outlook
25/02/13		315.92KB	Share
CIRCompany Secretary Appointment/Resignation
22/02/13		22.25KB	Share
CIRCompany Secretary Appointment/Resignation
20/02/13		21.9KB	Share
CIRHalf Year Report & Accounts
18/02/13	PRICE SENSITIVE	409.53KB	Share
CIRR&D Tax Incentive - Circadian Receives $1.3m
07/02/13	PRICE SENSITIVE	26.94KB	Share
CIRVGX-100 Phase 1 Clinical Trial Program Update
04/02/13	PRICE SENSITIVE	1.08MB	Share
CIRCompany Presentation at JP Morgan Biotech Showcase
10/01/13		3.21MB	Share
CIRChange of Director's Interest Notice
17/12/12		71.13KB	Share
CIROpen Briefing - CEO on Business Separation
11/12/12		210.4KB	Share
CIRChange of Director's Interest Notice
21/11/12		71.26KB	Share
CIRAppendix 3B
21/11/12		122.67KB	Share
CIRResults of Meeting
20/11/12		40.12KB	Share
CIRCEO AGM Presentation to shareholders
20/11/12		1.29MB	Share
CIRChairman's Address to Shareholders
20/11/12		253.66KB	Share
CIRLicence Grant To Bio-Rad
15/11/12	PRICE SENSITIVE	32.36KB	Share
CIRVGX-100 Poster Presentation at EORTC
08/11/12	PRICE SENSITIVE	315.62KB	Share
CIRVGX-100 Top 10 oncology candidate Windhover Conference
07/11/12		32.34KB	Share
CIRAusBiotech Presentation Company Update
02/11/12		951.89KB	Share
CIRAnnual Report / Notice of AGM & Proxy Form
22/10/12		1.39MB	Share
CIRDirector Appointment/Resignation
02/10/12		25.96KB	Share
CIROpen Briefing
24/09/12		304.54KB	Share
CIRAppendix 3B
24/08/12		122.36KB	Share
CIRNotice under section 708A(5)(e) of the Corporations Act 2001
24/08/12		23.47KB	Share
CIRPreliminary Final Report
23/08/12	PRICE SENSITIVE	1.31MB	Share
PER +CIRChange in substantial holding from CIR
17/07/12		42.05KB	Share
CIRAppendix 3Y
12/07/12		37.55KB	Share
CIRAppendix 3Y
10/07/12		37.49KB	Share
CIRAnalyst Report on Website
09/07/12		28.33KB	Share
CIRCommercial launch of CUP Test
27/06/12	PRICE SENSITIVE	46.09KB	Share
CIRAppendix 3B
22/06/12		121.86KB	Share
CIR708A Notice
22/06/12		23.46KB	Share
CIRPlacement
12/06/12	PRICE SENSITIVE	37.49KB	Share
CIRReinstatement to Official Quotation
12/06/12	PRICE SENSITIVE	30.35KB	Share
CIRSuspension From Official Quotation
06/06/12	PRICE SENSITIVE	77.8KB	Share
CIRCompany's Request for Suspension
06/06/12		124.26KB	Share
CIRRequest for Trading Halt
05/06/12		23.46KB	Share
CIRTrading Halt
05/06/12	PRICE SENSITIVE	30.43KB	Share
CIRUpdated Corporate Presentation
01/06/12		1.42MB	Share
CIRAppendix 3B
16/05/12		112.38KB	Share
CIRCeasing to be a substantial holder
26/04/12		42KB	Share
CIRChange of Director's Interest Notice
02/04/12		29.16KB	Share
PER +CIRChange in substantial holding from CIR - Updated
30/03/12		43.29KB	Share
CIRChange in substantial holding - ANP
29/03/12		43.58KB	Share
CIRAnalyst Report on Website
15/03/12		28.42KB	Share
CIRHealthscope publishes data on CUP Test
09/03/12	PRICE SENSITIVE	273.54KB	Share
CIROpen Briefing - CEO on H1 Results and Outlook
20/02/12	PRICE SENSITIVE	326.06KB	Share
CIRHalf Yearly Report and Accounts
16/02/12	PRICE SENSITIVE	432.74KB	Share
CIRVGX-100 potential for improving corneal graft survival
30/01/12	PRICE SENSITIVE	40.29KB	Share
CIRCEO Presentation at Biotech Showcase San Francisco
12/01/12		1.14MB	Share
CIRCircadian commences first Phase 1 clinical trial of VGX-100
09/01/12	PRICE SENSITIVE	32.42KB	Share
CIRChange of Director's Interest Notice
21/12/11		34.37KB	Share
CIRFinance News Network Interview with CEO
19/12/11		28.8KB	Share
CIRChange of Director's Interest Notice
13/12/11		39.41KB	Share
CIRFinal Director's Interest Notice
25/11/11		17.51KB	Share
CIRResults of Meeting
24/11/11		38.37KB	Share
CIRCEO Presentation to AGM
24/11/11		702.45KB	Share
CIRAGM Chairman's Address to Shareholders
24/11/11		45.11KB	Share
CIROpen Briefing - CEO on IND Status for VGX-100
15/11/11	PRICE SENSITIVE	332.69KB	Share
CIRFDA approves IND for VGX-100
31/10/11	PRICE SENSITIVE	183.66KB	Share
CIRChange of Director's Interest Notice
25/10/11		33.94KB	Share
CIRNotice of Annual General Meeting/Proxy Form/Annual Report
24/10/11		2.62MB	Share
CIRChange of Director's Interest Notice
20/10/11		33.99KB	Share
CIRFinal Director's Interest Notice
18/10/11		17.59KB	Share
CIRAnalyst Investment Reports on Circadian Website
11/10/11		29.31KB	Share
CIRCircadian Corporate Presentation to Biopartnering Europe
11/10/11		1.27MB	Share
CIRClinical validation study of CUP Test commences
10/10/11	PRICE SENSITIVE	50.18KB	Share
CIRRetirements from Circadian Board of Directors
03/10/11		28.08KB	Share
CIRCircadian files IND with FDA for VGX-100
30/09/11	PRICE SENSITIVE	45.83KB	Share
CIROpen Briefing - CEO on FY12 Outlook and VGX-100 Progress
15/09/11	PRICE SENSITIVE	366.46KB	Share
CIRVGX-100 potential new therapy for Dry Eye Disease
13/09/11	PRICE SENSITIVE	41.45KB	Share
CIRKey appointment in clinical trials management
12/09/11		30.01KB	Share
CIRChange of Director's Interest Notice
09/09/11		25.29KB	Share
CIRChange of Director's Interest Notice
07/09/11		25.33KB	Share
CIRChange of Director's Interest Notice
07/09/11		24.92KB	Share
CIRUpdated Corporate Presentation
07/09/11		2.91MB	Share
CIRChange of Director's Interest Notice
06/09/11		25.31KB	Share
CIR +OILChange in substantial holding from CIR
31/08/11		31.09KB	Share
CIRChange of Director's Interest Notice
31/08/11		25.33KB	Share
CIRChange of Director's Interest Notice
30/08/11		28.46KB	Share
CIRPreliminary Final Report
23/08/11	PRICE SENSITIVE	1.19MB	Share
CIRChange of Director's Interest Notice
25/07/11		29.13KB	Share
CIRChange of Director's Interest Notice
18/07/11		28.46KB	Share
CIROpen Briefing - CEO on VGX-100 Clinical Development Plans
14/07/11	PRICE SENSITIVE	313.09KB	Share
CIRMarket Update Presentation
16/06/11		2.7MB	Share
CIRCircadian launches level 1 ADR Program and OTCQX in US
14/06/11	PRICE SENSITIVE	58.59KB	Share
PER +CIRChange in substantial holding from CIR
10/06/11		28.77KB	Share
CIRVEGF-C and VEGF-D Identified as Biomarkers
07/06/11	PRICE SENSITIVE	542.49KB	Share
CIRAnalyst Investment Reports on Circadian Website
30/05/11		26.05KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

CIRCADIAN TECHNOLOGIES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available